Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain. (Record no. 25256468)

MARC details
000 -LEADER
fixed length control field 01357 a2200373 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517052553.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201709s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1578-2190
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1016/j.ad.2015.07.006
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Puig, L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20170919
245 00 - TITLE STATEMENT
Title Model for assessing the efficiency of biologic drugs in the treatment of moderate to severe psoriasis for one year in clinical practice in Spain.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Actas dermo-sifiliograficas
Date of publication, distribution, etc.
300 ## - PHYSICAL DESCRIPTION
Extent 34-43 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adalimumab
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biological Products
General subdivision economics
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Decision Trees
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Etanercept
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infliximab
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Meta-Analysis as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Psoriasis
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Reproducibility of Results
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Spain
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Ustekinumab
General subdivision therapeutic use
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name López-Ferrer, A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Vilarrasa, E
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name García, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Fernández-del Olmo, R
773 0# - HOST ITEM ENTRY
Title Actas dermo-sifiliograficas
Related parts vol. 107
-- no. 1
-- p. 34-43
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1016/j.ad.2015.07.006">https://doi.org/10.1016/j.ad.2015.07.006</a>
Public note Available from publisher's website

No items available.